$3.90
-0.110 (-2.74%)
At Close: Jun 05, 2026
Orocidin and Bio-Convert expects to begin pilot efficacy studies in 2025
03:00pm, Tuesday, 17'th Dec 2024
BEVERLY HILLS, California, Dec. 17, 2024 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTCQB:NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in providing
NORDICUS now trading under symbol NORD
07:00am, Tuesday, 10'th Dec 2024
BEVERLY HILLS, California, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTCQB:NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in providing
Nordicus Partners Corporation Acquires the Remaining 5% Shares In Orocidin A/S
09:15am, Tuesday, 12'th Nov 2024
Beverly Hills, California., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in providin
Nordicus Partners Corporation Acquires Bio-Convert ApS
02:50pm, Monday, 11'th Nov 2024
Beverly Hills, California., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in providin
Nordicus Partners Corporation Announces Reverse Stock Split
09:15am, Thursday, 07'th Nov 2024
Beverly Hills, California., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in providin
Nordicus Partners To Host Investor Relations Webinar on July 10, 2024
09:15am, Wednesday, 03'rd Jul 2024
Beverly Hills, California., July 03, 2024 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in providin
Nordicus Partners Corporation Enters Into A Consultancy Agreement With BIO-CONVERT In Denmark
02:37pm, Friday, 21'st Jun 2024
Beverly Hills, California., June 21, 2024 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in providin
Orocidin – New Insights Into The Treatment Of Periodontitis
09:15am, Tuesday, 11'th Jun 2024
Beverly Hills, California., June 11, 2024 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in providin
Nordicus Partners Corporation Appoints Peter Severin as Chairman Of The Board of Directors
01:53pm, Tuesday, 04'th Jun 2024
Beverly Hills, California, June 04, 2024 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in providing
Nordicus Partners Corporation Engages FORCE Family Office
10:29am, Thursday, 23'rd May 2024
Beverly Hills, California., May 23, 2024 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in providing
Nordicus Partners Corporation Acquires 95% Stake in Orocidin A/S
12:29pm, Wednesday, 15'th May 2024
Beverly Hills, California., May 15, 2024 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in providing
Nordicus Partners Corporation Uplists to OTCQB
09:48am, Thursday, 09'th May 2024
Beverly Hills, California., May 09, 2024 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTCQB: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in providing
NORDICUS PARTNERS CORPORATION ENTERS INTO A CONSULTANCY AGREEMENT WITH OROCIDIN A/S IN DENMARK
03:54pm, Wednesday, 10'th Jan 2024
Beverly Hills, California., Jan. 10, 2024 (GLOBE NEWSWIRE) -- Nordicus Partners Corporation (OTC PINK: NORD) (“Nordicus” or the “Company”), a financial consulting company specializing in provi
Sign In
Buy NORD